Involvement Of Pro- And Anti-Inflammatory Cytokines In Sepsis
Jean-Marc Cavaillon, M. Adib-Conquy
Published 2002 · Medicine
Download PDFAnalyze on Scholarcy
This paper references
Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae.
P. Moore (1993)
Dithiocarbamates ameliorate the effects of endotoxin in a rabbit model of disseminated intravascular coagulation.
A. Drollinger (1999)
Circulating cytokines: the tip of the iceberg?
J. Cavaillon (1992)
Dysregulation of in vitro cytokine production by monocytes during sepsis.
C. Múñoz (1991)
Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients.
A. Waage (1986)
Tumour necrosis factor-alpha and interleukin-8 inhibit neutrophil migration in vitro and in vivo
F. Cunha (1992)
Migration inhibitory factor expression in experimentally induced endotoxemia.
M. Bacher (1997)
Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin
Arrest of endotoxin-induced hypotension by transforming growth factor beta1.
M. A. Perrella (1996)
Role of NFkappaB in the mortality of sepsis.
H. Böhrer (1997)
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock
T. Calandra (1990)
IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice.
E. Bohn (1998)
Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein.
R. Shenkar (1999)
Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: role of T cell-dependent production of interferon-gamma.
A. Nansen (1997)
Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon.
F. Heinzel (1994)
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
S. Okusawa (1988)
Serum tumor necrosis factor levels in patients with infectious disease and septic shock.
F. Offner (1990)
Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma.
M. Keel (1996)
Evidence for Tumor Necrosis Factor‐induced Pulmonary Microvascular Injury After Intestinal Ischemia—Reperfusion Injury
M. Caty (1990)
NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance.
M. Adib-Conquy (2000)
T cell mediated lethal shock induced by bacterial superantigens.
H. Wagner (1992)
High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor.
T. Yoshimoto (1992)
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.
D. J. Berg (1995)
The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.
J. Mancilla (1993)
Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis
A. Luger (1986)
Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.
C. McCall (1993)
Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock
P. Li (1995)
The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B.
M. Schmitz (1991)
Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.
J. Rothstein (1988)
Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor.
T. Standiford (1995)
Expression and Contribution of Endogenous IL-13 in an Experimental Model of Sepsis1
A. Matsukawa (2000)
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor
T. Calandra (1994)
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis.
L. Brunet (1997)
Interleukin-8 in sepsis: relation to shock and inflammatory mediators.
C. E. Hack (1992)
Multiple roles for IL-12 in a model of acute septic peritonitis.
M. Steinhauser (1999)
Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock.
S. Endo (1995)
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
C. Gérard (1993)
The Pro-Inflammatory Cytokine Cascade
Jean-Marc Cavaillon (2002)
Pivotal Role of the CC Chemokine, Macrophage-Derived Chemokine, in the Innate Immune Response1
A. Matsukawa (2000)
Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits.
K. Aiura (1993)
Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death
Z. Liu (1996)
Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis
M. Bozza (1999)
Effects of granulocyte colony-stimulating factor on bacterial translocation due to burn wound sepsis
O. Yalçin (2006)
Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.
T. van der Poll (1995)
The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation
F. Wulczyn (1996)
Early activation of pulmonary nuclear factor kappaB and nuclear factor interleukin-6 in polymicrobial sepsis.
W. Browder (1999)
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.
K. V. Van Zee (1992)
MCP-1 protects mice in lethal endotoxemia.
D. Zisman (1997)
Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice.
S. Basu (1997)
Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
E. Girardin (1992)
Early activation of hepatic NFkappaB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality.
D. Williams (1999)
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.
E. Hirsch (1996)
Elevated Levels of Circulating Transforming Growth Factor- 1 in Patients with the Sepsis Syndrome
C. Marie (1996)
Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis.
E. Presterl (1997)
Cutting Edge: IL-15 Costimulates the Generalized Shwartzman Reaction and Innate Immune IFN-γ Production In Vivo1
T. Fehniger (2000)
Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
G. Doherty (1992)
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.
J. David (1966)
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.
T. van der Poll (1996)
Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.
M. van Deuren (1995)
Effect of endotoxin in IL-1 beta-deficient mice.
G. Fantuzzi (1996)
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
K. Tracey (1987)
Transforming growth factor‐β negatively modulates T‐cell responses in sepsis
S. Ahmad (1997)
Interleukin-12: Role of Interferon-γ in IL-12 Adverse Effects
B. Ryffel (1997)
Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*)
J. Raingeaud (1995)
Detection of Macrophage Inflammatory Protein (MIP)-1α and MIP-β during Experimental Endotoxemia and Human Sepsis
N. O'grady (1999)
Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
K. Burns (2000)
Circulating interleukin‐8 concentrations in patients with multiple organ failure of septic and nonseptic origin
C. Marty (1994)
Decreased G-CSF and IL-3 Production and Gene Expression from Mononuclear Cells of Newborn Infants
M. Cairo (1992)
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome
A. Waage (1989)
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.
E. Kopp (1999)
Tumor Necrosis Factor Signaling to Stress-activated Protein Kinase (SAPK)/Jun NH2-terminal Kinase (JNK) and p38
T. Yuasa (1998)
Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men.
T. Pollmächer (1996)
Increased plasma levels of interleukin-6 in sepsis [see comments]
C. E. Hack (1989)
Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans.
M. Lantz (1990)
Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis.
M. Astiz (1996)
Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin.
H. L. Preas (1996)
Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats.
M. Chang (1996)
Sepsis: a new hypothesis for pathogenesis of the disease process.
R. Bone (1997)
Elevated Plasma Concentrations of Interferon (IFN)–γ and the IFN‐γ–Inducing Cytokines Interleukin (IL)–18, IL‐12, and IL‐15 in Severe Melioidosis
F. Lauw (1999)
A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock
Y. Chvatchko (2000)
Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia
M. Block (1993)
Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions.
M. Gimbrone (1989)
Dynamics of blood cytokine concentrations in patients with bacteremic infections.
P. Kragsbjerg (1996)
IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
D. Jovanovic (1998)
The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.
T. Fujita (1993)
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide
R. Kamijo (1993)
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality.
E. Miller (1992)
Role of Interferon- γ and Nitric Oxide in Pulmonary Edema and Death Induced by Lipopolysaccharide
H. Heremans (2000)
Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
S. Opal (1999)
Transforming Growth Factor-β1 Inhibits Synthesis of Cytokines in Endotoxin-Stimulated Human Whole Blood
I. Karres (1996)
Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci.
G. Mancuso (1997)
rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia.
B. Freeman (1997)
The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
G. Franzoso (1993)
Possibilities and problems of cytokine measurements
Jean-Marc Cavaillon (1999)
THE PATHOGENESIS OF EXPERIMENTAL TOXIC SHOCK SYNDROME: THE ROLE OF INTERLEUKIN-2 IN THE INDUCTION OF HYPOTENSION AND RELEASE OF CYTOKINES
M. Tokman (1995)
The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
D. Ballard (1992)
Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
P. Jansen (1996)
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
A. Ashkenazi (1991)
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
R. Medzhitov (1997)
MyD88, an Adapter Protein Involved in Interleukin-1 Signaling*
K. Burns (1998)
NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome.
P. Moine (2000)
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
E. Girardin (1988)
Dissociation between plasma and monocyte-associated cytokines during sepsis.
C. Múñoz (1991)
Role of Interferon-γ in Experimental Gram-Negative Sepsis
A. T. Silva (1992)
Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model.
H. Redl (1991)
Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.
C. Marie (1997)
Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes [published erratum appears in J Exp Med 1996 Nov 1;184(5):2075]
P. Brandtzaeg (1996)
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15.
T. Musso (1999)
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
C. Gabay (1997)
Biological response to intravenously administered endotoxin in patients with advanced cancer.
R. Engelhardt (1990)
Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
T. van der Poll (1993)
Le rtrocontrle ngatif de l'inflammation: rle des cytokines antiinflammatoires
C. Marie (1997)
The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity.
C. Hauser (1997)
Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.
P. Damas (1992)
IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition.
D. Alleva (1997)
DELAYED HYPERSENSITIVITY IN VITRO. II. EFFECT OF SENSITIVE CELLS ON NORMAL CELLS IN THE PRESENCE OF ANTIGEN.
J. David (1964)
Interferon-α prevents endotoxin-induced mortality in mice
S. Tzung (1992)
Detection of circulating bacterial superantigen and lymphotoxin-a in patients with streptococcal toxic-shock syndrome
S. Sriskandan (1996)
N-acetyl-leucinyl-leucinyl-norleucinal inhibits lipopolysaccharide-induced NF-kappaB activation and prevents TNF and IL-6 synthesis in vivo.
S. Schow (1997)
Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.
M. Kretzschmar (1992)
EX VIVO T‐LYMPHOCYTE DERIVED CYTOKINE PRODUCTION IN SIRS PATIENTS IS INFLUENCED BY EXPERIMENTAL PROCEDURES
J. Muret (2000)
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
S. Donnelly (1993)
Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees.
F. Lauw (1999)
Compartmentalised inducible nitric-oxide synthase activity in septic shock
D. Annane (2000)
Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
M. Rogy (1994)
Role of Interleukin-18 (IL-18) during Lethal Shock: Decreased Lipopolysaccharide Sensitivity but Normal Superantigen Reaction in IL-18-Deficient Mice
P. Hochholzer (2000)
Protection from septic shock by neutralization of macrophage migration inhibitory factor
T. Calandra (2000)
ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE
A. Waage (1987)
Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome.
L. Armstrong (2000)
Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production
P. Kanakaraj (1998)
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
M. Wysocka (1995)
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
S. Ghosh (1998)
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
J. DiDonato (1997)
Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
C. Marie (1997)
Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors.
W. Junger (1995)
Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.
Y. Fong (1989)
Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality.
W. Lesslauer (1991)
The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress Syndrome
S. C. Donnelly (1996)
Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.
V. Modur (1997)
Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children.
M. Arditi (1990)
A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy.
X. Du (1994)
Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome.
S. Hashimoto (2000)
Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septic and healthy preterms
M. Kantar (2000)
Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome.
R. Jacobs (1989)
Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis.
P. Villa (1998)
IL-9 Protects Mice from Gram-Negative Bacterial Shock: Suppression of TNF-α, IL-12, and IFN-γ, and Induction of IL-10
U. Grohmann (2000)
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
R. Shimazu (1999)
Cytokine elevations in infants with bacterial and aseptic meningitis.
S. Dulkerian (1995)
Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy.
V. Broaddus (1994)
In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock.
S. Liu (1997)
Endogenous IL-10 protects mice from death during septic peritonitis.
T. van der Poll (1995)
Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13.
T. van der Poll (1997)
Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome.
J. H. Pruitt (1996)
Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta
F. Randow (1995)
Reduced Ex Vivo Interleukin-8 Production by Neutrophils in Septic and Nonseptic Systemic Inflammatory Response Syndrome
C. Marie (1998)
HMG-1 as a late mediator of endotoxin lethality in mice.
H. Wang (1999)
Detection of cytoplasmic IL‐1β in peripheral blood mononuclear cells from intensive care unit (ICU) patients
S. Yentis (1995)
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
V. Bours (1992)
Early activation of pulmonary nuclear factor κB and nuclear factor interleukin-6 in polymicrobial sepsis. Discussion
W. Browder (1999)
Tumor necrosis factor. Alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury.
S. Leeper-Woodford (1991)
Inadequate Interleukin 2 Production: A Fundamental Immunological Deficiency in Patients with Major Burns
J. J. Wood (1984)
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
B. Beutler (1985)
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.
E. Fischer (1992)
The 1996 Moyer Award. Effects of endotoxin on the Th1/Th2 response in humans.
S. Zimmer (1996)
Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis.
P. Zhang (1998)
MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
N. Malinin (1997)
High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.
B. Derkx (1995)
Inhibition of HIV progression by dithiocarb
E. Reisinger (1990)
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
S. J. Deventer (1990)
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.
M. Pinsky (1993)
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.
E. Fischer (1992)
The role of IFN-gamma in the pathology of experimental endotoxemia.
F. Heinzel (1990)
Neutralization of IL-18 Reduces Neutrophil Tissue Accumulation and Protects Mice Against Lethal Escherichia coli and Salmonella typhimurium Endotoxemia1
M. Netea (2000)
IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock.
Y. Sakao (1999)
Circulating levels of IL‐11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute‐phase proteins by the liver
C. Gabay (1996)
Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.
P. Jansen (1996)
Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis.
D. Villers (1995)
Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity.
B. Gårdlund (1995)
Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids.
P. Waring (1992)
Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
M. van Deuren (1994)
Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans
T. Poll (1991)
Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures.
A. Puren (1998)
Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit.
J. Friedland (1996)
High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.
T. Calandra (1991)
Tumor necrosis factor and septic shock.
L. Baud (1990)
Cytokines in Streptococcal Infections
Jean-Marc Cavaillon (1997)
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
J. Bernhagen (1993)
Dual effect of IL-4 on resistance to systemic gram-negative infection and production of TNF-alpha.
A. Giampietri (2000)
Differential alterations in plasma colony‐stimulating factor concentrations in meningococcaemia
P. Waring (1995)
Inhibition of the Defense System Stimulating Interleukin-12 Interferon-γ Pathway During Critical Illness
W. Ertel (1997)
MEK Kinase Is Involved in Tumor Necrosis Factor α-Induced NF-κB Activation and Degradation of IκB-α*
M. Hirano (1996)
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13.
F. Nicoletti (1997)
MIF as a glucocorticoid-induced modulator of cytokine production
T. Calandra (1995)
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
K. Ohlsson (1990)
Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase.
J. Westwick (1994)
The nonspecific nature of endotoxin tolerance.
J. Cavaillon (1995)
Interleukin-4 prevents mortality from acute but not chronic murine peritonitis and induces an accelerated tumor necrosis factor-alpha response.
R. Sawyer (1996)
Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis.
G. Hamilton (1992)
IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
H. Tsutsui (1997)
Sequential Measurements of Chemokines in Urosepsis and Experimental Endotoxemia
D. Olszyna (2004)
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.
H. Tilg (1994)
Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs.
S. Liu (1999)
Interleukin‐16 stimulates the expression and production of pro‐inflammatory cytokines by human monocytes
N. Mathy (2000)
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
A. Baldwin (1996)
Interleukin-10 production during septicaemia
A. Marchant (1994)
Interleukin-1 receptor antagonist production during infectious and noninfectious systemic inflammatory response syndrome
C. Marie (2000)
High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients.
F. Riché (1996)
ELISA detection of circulating levels of LIF, OSM, and CNTF in septic shock.
C. Guillet (1995)
Anti-inflammatory cytokine profile and mortality in febrile patients
J. Dissel (1998)
Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection.
J. Friedland (1992)
IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production.
T. Muchamuel (1997)
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.
J. Giri (1994)
Endotoxin‐stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin‐1βin vitro during infectious peritonitis
M. Fieren (1990)
Activation of Transcription Factor NF-κB and p38 Mitogen-activated Protein Kinase Is Mediated by Distinct and Separate Stress Effector Pathways*
S. Wesselborg (1997)
Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor.
B. François (1997)
Detection of Undegraded Oligonucleotides in Vivo by Fluorescence Resonance Energy Transfer
H. Uchiyama (1996)
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.
A. Bossink (1995)
Interferon gamma receptor deficient mice are resistant to endotoxic shock
B. Car (1994)